Report Scope:

The scope of this study entails the worldwide market for thawing systems. The report covers the entire market for thawing systems, which incorporates four sample types: blood, embryo and ovum, semen, and stem cells. Based on the end user, thawing systems are divided into blood bank and transfusion centers, hospitals and diagnostic centers, biotechnology and pharma companies, and research and academic institutes.

By geographical region, the market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. For market estimates, data has been provided for the year 2021 as the base year, with forecasts for 2022-2027. Estimated values are based on device manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 25 tables
  • An overview of the global markets for thawing systems
  • Estimation of market size and analyses of global market trends, with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Coverage of history and principles of cryopreservation, and discussion on impact of cryopreservation and freeze-thawing on therapeutic properties
  • Assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the thawing systems market
  • Discussion on the implications of thawing systems in the context of the current size and growth of the medical device market, and description of important technologies that supports thawing devices
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Profiles of the key companies in the thawing systems market, including BioLife Solutions Inc., Cardinal Health, Sartorius, Cytiva Life Sciences, Boekel Scientific, FreMon Scientific Inc., and Helmer Scientific Inc.